Evo Fund Discloses 9.9% Stake and New Warrant Subscription in Super League
SLE has more than doubled off its 52-week low of $2.12.
Summary
Evo Fund disclosed a 9.9% stake in Super League and a new warrant subscription for up to 10 million shares, alongside a small open-market sale, in connection with the Metaplanet acquisition.
Key Events · Ownership and Investor Activity · SLE
-
Evo Fund Reports 9.9% Stake
Evo Fund beneficially owns 221,697 shares (9.9% of 1,997,573 outstanding), including 184,997 common shares and 36,700 shares underlying currently exercisable warrants.
-
New Warrant Subscription for 10M Shares
On August 18, 2026, Evo Fund entered a subscription agreement to receive two warrants to purchase up to 10,000,000 shares at exercise prices from $3.00 to $5.55 per share, with a two-year term, contingent on stockholder approval of the Metaplanet acquisition.
-
Open-Market Sale of 3,729 Shares
Evo Fund sold 3,729 shares of common stock in the open market on August 18, 2026, the same day the Metaplanet acquisition was announced.
-
Warrant Exercise and Exchange
On August 14, 2026, Evo Fund exchanged its October 2025 Pre-Funded Warrant for new pre-funded warrants to purchase 833,334 shares and partially exercised the new warrant to acquire 123,300 shares.
Analysis · SLE · Technology
Evo Fund, a Cayman Islands investment vehicle managed by Michael Lerch, has disclosed a 9.9% beneficial ownership stake in Super League Enterprise. The filing reveals a new subscription agreement for warrants to purchase up to 10 million shares at $3.00–$5.55 per share, contingent on stockholder approval of the Metaplanet acquisition. This adds a significant potential overhang and aligns Evo Fund's interests with the pending acquisition, while the open-market sale of 3,729 shares on August 18 suggests some profit-taking amid the deal announcement.
At the time of this filing, SLE was trading at $4.30 on NASDAQ in the Technology sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $2.12 to $137.16. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.